FGF2 and osteosarcoma: When investigating the expression of PPARGC1A, in the samples Ch-P4, L-P5, and Rm-P6, treatments with AA bFGF and DHA bFGF lead to an increase in its expression, while this effect is not observed in osteosarcomas.